Editorial: Risk and Benefit of Restrictive Transfusion Strategies in Neurocritically Ill Patients https://ja.ma/3YYgxIp
JAMA
图书期刊出版业
Chicago，Illinois 162,135 位关注者
JAMA is an international peer-reviewed general medical journal published online daily and in print weekly.
关于我们
JAMA, published continuously since 1883, is an international peer-reviewed general medical journal. JAMA is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. JAMA is the most widely circulated general medical journal in the world, with more than 289,000 recipients of the print journal, more than 1.5 million recipients of electronic tables of contents and alerts, and over 30 million annual visits to the journal's website. JAMA is published 48 times per year in print/online issues, and new articles are published several times a week online. Without any author fees, all research articles are made free access online 6 months after publication on the JAMA website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program. Kirsten Bibbins-Domingo, PhD, MD, MAS, is the Editor in Chief of JAMA,. JAMA is a member of the International Committee of Medical Journal Editors, cosponsors the International Congress on Peer Review and Biomedical Publication, and is a member of the African Journal Partnership Project and is partnered with the Malawi Medical Journal. JAMA's key objective is to promote the science and art of medicine and the betterment of the public health. JAMA ISSN 0098-7484 (Print) ISSN 1538-3598 (Online)
- 网站
-
https://ja.ma/JAMA
JAMA的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 1,001-5,000 人
- 总部
- Chicago，Illinois
- 类型
- 非营利机构
- 创立
- 1883
- 领域
- Internal Medicine、Dermatology、Neurology、Surgery、Pediatrics、Ophthalmology、Otolaryngology、General Psychiatry、Cardiology、Oncology、Health Policy、Psychiatry、Surgery、Cardiology、Hypertension、Cholesterol、Diabetes和Cancer
地点
-
主要
获取路线
330 N Wabash Ave
US，Illinois，Chicago，60611
JAMA员工
动态
-
A liberal transfusion strategy compared with a restrictive strategy resulted in a lower rate of unfavorable neurological outcome among patients with acute brain injury. https://ja.ma/3V7Lo4a @fabio_taccone
-
-
Among patients with unilateral pathologic high-risk retinoblastoma, 3 cycles of carboplatin, etoposide, and vincristine (CEV) chemotherapy resulted in 5-year disease-free survival that was noninferior to 6 cycles of CEV chemotherapy. https://ja.ma/3V5zc3N
-
-
The addition of H pylori stool antigen testing to fecal immunochemical testing (FIT) screening did not significantly reduce gastric cancer incidence or mortality. https://ja.ma/3Zjyan6
-
-
Allergic rhinitis may cause nasal congestion, runny nose, postnasal drip, sneezing, and itching of the eyes, nose, and throat. This JAMA Patient Page describes allergic rhinitis and its risk factors, diagnosis, and treatment. https://ja.ma/3ZdB64R
-
-
Although anal cancer is rare in the general population, it develops at higher rates among certain populations. This JAMA Insights examines the treatment and rising prevalence of anal cancer in the US in high-risk groups. https://ja.ma/415kIEG
-
-
Most viewed in the last 7 days from JAMA: Muvalaplin reduced lipoprotein(a) measured using intact lipoprotein(a) and apolipoprotein(a)-based assays and was well tolerated. https://ja.ma/3ZjmqRK
-
-
The recombinant SARS-CoV-2 variant XEC is spreading globally and may become dominant, but current vaccines are expected to provide protection against severe disease. Read more in JAMA Medical News: https://ja.ma/3Zif29d
-
-
Author Robert Califf, commissioner of the US Food and Drug Administration, joins JAMA+ AI Editor in Chief Roy Perlis to discuss AI regulation. https://ja.ma/4i2O0du
-
-
The Wilderness Medical Society’s 2024 guideline update provides a concise risk stratification tool, assessment after COVID-19 infection, clarification on diagnosis, and updated findings on staged ascent and hypoxic tents. https://ja.ma/3CAwxZE
-